Osteoclast Integrins: Adhesion and Signaling

Advances in Organ Biology

Volumn 5, Issue C, 1998, Pages 315-329

  Shankar, Geetha ^a   Horton, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0142082373     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60123-8     Document Type: Article

References (75)

1. Athanasou N.A., Alvarez J.I., Ross F.P., Quinn J.M., and Teitelbaum S.L. Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes. Calcif. Tissue Int. 50 (1992) 427-432
2. Arroyo A.G., Campanero M.R., Sánchez-Mateos P., Zapata J.M., Ursa M.A., del. Poza M.A., and Sanchez-Madrid F. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase. J. Cell Biol. 126 (1994) 1277-1286
3. Aubin J.E. Perspectives-Osteoclast adhesion and resorption: The role of podosomes. J. Bone Min Res. 7 (1992) 365-368
4. In: Barclay A.N., Birkeland M.L., Brown M.H., Beyers A.D., Davis S.J., Somoza C., and Williams A.F. (Eds). The Leucocyte Antigen Factsbook (1993), Academic Press, London
5. Beckstead J.H., Stenberg P.E., McEver R.P., Shuman M.A., and Bainton D.F. Immunohistochemical localization of membrane and α-granule proteins in human megakaryocytes: Application to plastic embedded bone marrow biopsy specimens. Blood 67 (1986) 285-293
6. Berry V., Rathod H., Pulman L.B., and Datta H.K. J. Endocrinol. (1994)
7. Chambers T.J., Fuller K., Darby J.A., Pringle J.A.S., and Horton M.A. Monoclonal antibodies against osteoclasts inhibit bone resorption in vitro. Bone Min. 1 (1986) 127-135
8. Chen H.-C., and Guan J.-L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. 91 (1994) 10148-10152
9. Clark E.A., and Brugge J.S. Integrins and signal transduction pathways: The road taken. Science 268 (1995) 233-239
10. Clover J., Dodds R.A., and Gowen M. Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture. J. Cell Sci. 103 (1992) 267-271
11. Cox D., Aoki T., Seki J., Motoyama Y., and Yoshida K. The pharmacology of integrins. Medicinal Res. Revs. 14 (1994) 195-228
12. Crippes B.A., Engleman V.W., Settle S.L., Ornberg R.L., Helfrich M.H., Horton M.A., and Nickols G.A. Antibody to β, integrin inhibits the calcemic response to PTHrP in the thyroparathyroidectomized rat. Endocrinol. 137 (1996) 918-924
13. Davies J., Warwick J., Totty N., Philp R., Helfrich M., and Horton M. The osteoclast functional antigen implicated in the regulation of bone resorption is biochemically related to the vitronectin receptor. J. Cell Biol. 109 (1989) 1817-1826
14. Engleman V.W., Nickols G.A., Ross F.P., Horton M.A., Griggs D.W., Settle S.L., Ruminski P.G., and Teitelbaum S.L. A peptidomimetic antagonist of the α(v)β3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J. Clin. Invest. 99 (1997) 2284-2292
15. Fisher J.E., Caulfield M.P., Sato M., Quartuccio H.A., Gould R.J., Garsky V.M., Rodan G.A., and Rosenblatt M. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD) -containing protein. Endocrinol. 132 (1993) 1411-1413
16. Flores M.E., Norgard M., Heinegard D., Reinholt F.P., and Andersson G. RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein and fibronectin. Exp. Cell Res. 201 (1992) 526-530
17. Gadek T., and Blackburn B.K. Identification and development of integrin/ligand antagonists for the treatment of human disease. In: Horton M.A. (Ed). Adhesion Receptors as Therapeutic Targets (1996), CRC Press Inc., Boca Raton, Florida 247-272
18. van der Geer P., Hunter T., and Lindberg R.A. Receptor protein-tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol. 10 (1994) 251-337
19. Hall T.J., Schaueblin M., and Missbach M. Evidence that c-src is involved in the process of osteoclastic bone resorption. Biochem. Biophys. Res. Comm. 199 (1994) 1237-1244
20. Hashizume Y., Araki S., Sawada K., Yamada K., and Katayama K. Adhesive substrates influence acid-producing activities of cultured rabbit osteoclasts: Cultured osteoclasts with large vacuoles have enhanced acid-productive activities. Exp. Cell Res. 218 (1995) 452-459
21. Helfrich M.H., Nesbitt S.A., Dorey E.L., and Horton M.A. Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a β, integrin. J. Bone Min. Res. 7 (1992) 335-343
22. Helfrich M.H., Nesbitt S.A., Lakkakorpi P., Barnes M.J., Bodary S.C., Shankar G., Mason W.T., Mendrick D.L., Väänänen H.K., and Horton M.A. β, integrin and osteoclast function: involvement in collagen recognition and bone resorption. Bone 4 (1996) 317-328
23. FAK to cellular focal adhesions. J. Cell Biol. 123 (1993) 993-1005
24. c-src in association with intracellularmembranes. J. Cell Biol. 119 (1992) 1003-1013
25. Horton M.A., and Davies J. Adhesion receptors in bone. J. Bone Min. Res. 4 (1989) 803-807
26. Horton M.A., Lewis D., McNulty K., Pringle J.A.S., and Chambers T.J. Monoclonal antibodies to osteoclastomas (giant cell bone tumours): Definition of osteoclast-specific antigens. Cancer Res. 45 (1985) 5663-5669
27. Horton M.A. Expression of platelet glycoprotein IIIa by human osteoclasts. Blood 68 (1986) 595
28. Horton M.A., and Rodan G.A. Integrins as therapeutic targets in bone disease. In: Horton M.A. (Ed). Adhesion Receptors as Therapeutic Targets (1996), CRC Press Inc., Boca Raton, Florida 223-245
29. 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Ann. N.Y. Acad. Sci. 760 (1995) 151-165
30. 3. J. Biol. Chem. 270 (1995) 9917-9925
31. Hughes D.E., Salter D.M., Dedhar S., and Simpson R. Integrin expression in human bone. J. Bone Min. Res. 8 (1993) 527-533
32. Hynes R.O. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69 (1992) 11-25
33. Ingber D.E., Prusty D., Frangioni J.V., Cragoe Jr. E.J., Lechene C., and Schwartz M.A. Control of intracellular pH and growth by fibronectin in capillary endothelial cells. J. Cell Biol. 110 (1990) 1803-1811
34. King K.L., D'Anza J.J., Bodary S., Pitti R., Siegel M., Lazarus R.A., Dennis M.S., Hammonds Jr. R.G., and Kukreja S.C. Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J. Bone Min. Res. 9 (1994) 381-387
35. 1 integrins. Proc. Natl. Acad. Sci. 88 (1991) 8392-8396
36. LaFlamme S.E., Thomas L.A., Yamada S.S., and Yamada K.M. Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin functions in receptor localization, cell spreading and migration, and matrix assembly. J. Cell Biol. 126 (1994) 1287-1298
37. 3, in osteoclasts. A study using confocal laser scanning microscopy. J. Cell Sci. 104 (1993) 663-670
38. Lakkakorpi P.T., Horton M.A., Helfrich M.H., Karhukorpi E.-K., and Väänänen H.K. Vitronectin receptor has a role in bone resorption but does not mediate tight sealing zone attachment of osteoclasts to the bone surface. J. Cell Biol. 115 (1991) 1179-1186
39. 3 and echistatin in osteoclasts during bone resorption in vivo. J. Bone Min. Res. 10 (1995) S164 Suppl. 1
40. Mbalaviele G., Chen H., Boyce B.F., Mundy G.R., and Yoneda T. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J. Clin. Invest. 95 (1995) 2757-2765
41. 3 integrin stimulates immediate cell signals in osteoclasts. J. Biol. Chem. 266 (1991) 20369-20374
42. Mould P.A., and Humphries M.J. Functional domains of adhesion molecules. In: Horton M.A. (Ed). Adhesion Receptors as Therapeutic Targets (1995), CRC Press, Boca Raton, Florida 75-105
43. Nakamura H., Kenmotsu S., Sakai H., and Ozawa H. Localization of CD44, the hyaluronidate receptor, on the plasma membrane of osteocytes and osteoclasts in rat tibiae. Cell Tiss. Res. 280 (1995) 225-233
44. Neff L., Gaiht J., and Baron R. Ultrastructural demonstration of the a. subunit of the vitronectin receptor in the sealing zone of resorbing osteoclasts. J. Bone Min. Res. 10 (1995) S329 Suppl. 1
45. Nesbitt S., Nesbit A., Helfrich M., and Horton M. Biochemical characterization of human osteoclast integrins. J. Biol. Chem. 268 (1993) 16737-16745
46. Paniccia R., Colucci S., Grano M., Serra M., Zallone A.Z., and Teti A. Immediate cell signal by bone-related peptides in human osteoclastlike cells. Am. J. Physiol. 265 (1993) C1289-C1297
47. Pawson T. Protein-tyrosine kinases. Nature 373 (1995) 477-478
48. Reinholt F.P., Hultenby K., Oldberg A., and Heinegard D. Osteopontin-a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 87 (1990) 4473-4475
49. Richardson A., and Parsons J.T. Signal transduction through integrins: A central role for focal adhesion kinase?. BioEssays 17 (1995) 229-236
50. 2+. Proc. Natl. Acad. Sci. 87 (1990) 9472-9476
51. Ridley A.J., and Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70 (1992) 401-410
52. Rifkin B.R., and Gay C.V. Biology and Physiology of the Osteoclast (1992), CRC Press, Boca Raton, Florida
53. Rosales C., O'Brien V., Komberg L., and Juliano R. Signal tranduction by cell adhesion receptors. Biochim. Biophys. Acta. 1242 (1995) 77-98
54. 3 potentiate bone resorption. J. Biol. Chem. 268 (1993) 9901-9907
55. Sastry S.K., and Horwitz A.F. Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra- and intracellular-initiated transmembrane signaling. Curr. Opin. Cell Biol. 5 (1993) 819-831
56. Sato M.L., Garsky V., Majeska R.J., Einhorn T.A., Murray J., Tashjian A.H., and Gould R.J. Structure-activity studies of the s-echistatin inhibition of bone resorption. J. Bone Min. Res. 9 (1994) 1441-1449
57. Sato M., Sardana M.K., Grasser W.A., Garsky V.M., Murray J.M., and Gould R.J. Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111 (1990) 1713-1723
58. Schaller M.D., and Parsons J.T. Focal adhesion kinase protein and associated proteins. Curr. Opin. Cell. Biol. 6 (1994) 705-710
59. Shankar G., Davison I., Helfrich M.H., Mason W.T., and Horton M.A. Integrin receptor-mediated mobilization of intranuclear calcium in rat osteoclasts. J. Cell Sci. 105 (1993) 61-68
60. Shankar G., Gadek T.R., Burdick D.J., Davison I., Mason W.T., and Horton M.A. Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: Integrin-dependent and -independent actions. Exptl. Cell Res. 219 (1995) 364-371
61. Soriano P., Montgomery C., Geske R., and Bradley A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64 (1991) 693-702
62. Stein P.L., Vogel H., and Soriano P. Combined deficiencies of src, fyn, and yes tyrosine kinases in mutant mice. Genes Devel. 8 (1994) 1999-2007
63. Takahashi N., Udagawa N., Tanaka S., Murakami H., Owan I., Tamura T., and Suda T. Postmitotic osteoclast precursors express macrophage-associated phenotypes. J. Bone Min. Res. 8 (1993) S396
64. Tanaka H., Sato M., Shinar D., and Rodan G.A. Echistatin inhibits osteoclast-like cell generation in the co-culture system of mouse osteoblastic cells and bone marrow cells. J. Bone Min. Res. 6 (1991) S148 Suppl. 1
65. 2+ concentration in cells from a human giant cell tumor of bone. Bone 17 (1995) 175-183
66. Tezuka K., Sato T., Kamioka H., Nijweide P.J., Tanaka K., Matsuo T., Ohta M., Kurihara N., Hakeda Y., and Kumegawa M. Identification of osteopontin in isolated rabbit osteoclasts. Biochem. Biophys. Res. Comm. 186 (1992) 911-917
67. Väänänen H.K., and Horton M.A. The osteoclast clear zone is a specialized cell-matrix adhesion structure. J. Cell Sci. 108 (1995) 2729-2732
68. Vuori K., and Ruoslahti E. Association of insulin receptor substrate-1 with integrins. Science 266 (1994) 1576-1578
69. Yamamoto M., Fisher J.E., Gentile M., Seedor J.G., Leu C.T., Rodan S.B., and Rodan G.A. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats. Endocrinology. 139 (1998) 1411-1419
70. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602
71. c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo. J. Clin. Invest. 91 (1993) 2791-2795
72. Zambonin-Zallone A., Teti A., Grano M., Rubinacci A., Abbadini M., Gaboli M., and Marchisio P.C. Immunocytochemical distribution of extracellular matrix receptors in human osteoclasts: A β, antigen is colocalized with vinculin and talin in the podosomes of osteoclastoma giant cells. Exp. Cell Res. 182 (1989) 645-652
73. Zaidi M., Alam A.S.M.T., Shankar V.S., Bax B.E., Bax C.M.R., Moonga B.S., Bevis P.J.R., Stevens C., Blake D.R., Pazianas M., and Huang C.L.-H. Cellular biology of bone resorption. Biol. Rev. 68 (1993) 197-264
74. 2+]i in rat osteoclasts and mouse-derived, osteoclastlike cells. Am. J. Physiol. 266 (1994) C376-C381
75. Zimolo Z., Wesolowski G., and Rodan G.A. Acid extrusion is induced by osteoclast attachment to bone: Inhibition by alendronate and calcitonin. J. Clin. Invest. 96 (1995) 2277-2283